Dr. Stuart Titus, Ph.D.
Chief Executive Officer & President
Dr. Stuart Titus, Ph.D., is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. by becoming its seventh investor. Titus’ is also a Wall Street veteran, where he was a bond trader for 11 years. Dr. Titus earned his undergraduate degree at Rollins College, and his Ph.D. from the Open International University.
“We were the first to create a U.S. pipeline of hemp-based CBD products to Brazil, Mexico and other countries, and we’ve had tremendous demand for our products. As we expand this pipeline in the coming years, we really believe we’ll see economic improvement not just in the United States, but all over the world.”
Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus is the co-founder and President of General Hemp, LLC which, with Titus at the helm, developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.
Titus’ diverse background in both finance and healthcare is the impetus behind his strong passion to help others by supporting the greater cannabis industry. A graduate of Rollins College in Winter Park, Florida, Titus majored in economics and minored in business administration. He got his start on Wall Street where he worked as a bond trader for eleven years, managing a trading and underwriting department as a V.P. for CS First Boston Corp. Titus then went on to earn his PhD from Open International University, an educational organization affiliated with the World Health Organization.
Dr. Titus holds a Fellowship with the American Academy of Pain Management and clinical association with the American Association of Integrative Medicine. He practiced as a British Physiotherapist for over fifteen years, running clinics that specialized in integrative pain management and injury rehabilitation, treating over 40,000 patients. His first-hand experience with therapeutic hemp oil products as nutritional supplements led him to Medical Marijuana Inc. and drives him to continue to support the emerging cannabis medical marijuana and industrial hemp industries in the United States and abroad.